AIMS65 Score
iatroX editorial team · Updated · Record checked · editorial policy
AIMS65 predicts in-hospital mortality in patients with acute upper GI bleeding using five simple criteria: Albumin <30, INR >1.5, altered Mental status, Systolic BP ≤90, and age ≥65.
inputs
evidence
derivation
Developed by Saltzman et al. (Gastrointest Endosc 2011) from a retrospective analysis of 29,222 patients with upper GI bleeding admissions in the US.
validation
AUROC for in-hospital mortality is 0.77–0.80. In comparative studies, AIMS65 performs comparably to full Rockall and APACHE II for mortality prediction but is simpler to calculate. GBS outperforms AIMS65 for predicting need for intervention.
guideline endorsements
AIMS65 was developed to estimate mortality and resource use in acute upper gastrointestinal bleeding. NICE CG141 recommends Blatchford at first assessment and full Rockall after endoscopy; it does not specify AIMS65 as the initial risk score.
references
- Saltzman JR, Tabak YP, Hyett BH, et al. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc. 2011;74(6):1215-1224.PMID: 21907980
- Stanley AJ, Laine L, Dalton HR, et al. Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study. BMJ. 2017;356:i6432.PMID: 28053181
- Supporting guidance — nice.org.uk (checked 14 November 2026).link ↗